Hans Vink, PhD

Dr. Hans Vink

Chief Science Officer/Director

Dr. Hans Vink, PhD is the Co-Founder and Chief Science Officer of Microvascular Health Solutions. A biomedical researcher and a pioneer in the study of the endothelial glycocalyx, Dr. Hans Vink developed the GlycoCheck technology system that allows the clinical assessment of the glycocalyx. He is often sought out to lecture at universities and medical institutions around the world due to his expertise in the science of glycocalyx observation and his passion for sharing his extensive understanding of the vascular system. Hans earned a PhD in Physics from the University of Amsterdam in 1994, where he began his study of the glycocalyx. He continued his research as a postdoctoral fellow at the University of Virginia, and returned to Amsterdam in 1997 to continue his work. He was awarded a Research Fellowship from the Royal Netherlands Academy of Arts and Sciences for his study of the glycocalyx from 2000 through 2005. In 2005 he became an Established Investigator of the Netherlands Heart Foundation. In 2006 he joined the department of Physiology at Maastricht University, where he continues glycocalyx research as a Principle Investigator within the Cardiovascular Research Institute Maastricht (CARIM). He has authored or contributed on more than 75 scholarly papers and reviews and he has been awarded several grants to further the study of the glycocalyx and its importance to human health.

hans vink
A pioneer in the study of the endothelial glycocalyx and a sought-after lecturer for ground-breaking research and studies of the glycocalyx